Q37* (p.Gln37Ter) variant of NRXN2 (Neurexin-2)
Q37* (p.Gln37Ter) in NRXN2 (Neurexin-2) is a protein-truncating change. Clinical records from UniProt describe it as variant assessed as somatic; high impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.80 / 1. The record also includes population frequency data and structural context.
Q37* (p.Gln37Ter) variant details
- p.Gln37Ter
- NCI-TCGA TCGA novel
- Variant assessed as somatic; high impact.
- Stop Gained
- Variant Prioritization Score for Impact Estimate 0.796
- CADD 37.00
- UniProt: Variant assessed as somatic; high impact.
- Most common in the Non-Finnish European population (allele frequency 1e-06)
- Structural context available